A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Myreen Tomas, MD
ACELYRIN Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lkh-Univ. Klinikum Graz Universitätsklinik Für Innere Medizin Klinische Abteilung Für Rheumatologie Und Immunologie
Graz, Austria
- Medizinische Universität Innsbruck/tirol Kliniken Gmbh Universitätsklinik Für Innere Medizin Ii
Innsbruck, Austria
- Vienna Medical University Department of Internal Medicine Iii Division of Rheumatology
Vienna, Austria
- Katholieke Universiteit Leuven
Leuven, Belgium
- Vesalion S.R.O.
Ostrava, Czechia
- Revmatologický Ústav
Prague, Czechia
- Medical Plus S.R.O.
Uherské Hradiště, Czechia
- Pv Medical Services S.R.O.
Zlín, Czechia
- Rheumatologische Schwerpunktpraxis
Berlin, Germany
- Schlosspark Klinik
Berlin, Germany
- Centrum Für Innovative Diagnostik Und Therapie Rheumatologie/immunologie
Frankfurt, Germany
- Universitätsklinikum Freiburg
Freiburg im Breisgau, Germany
- Rheumazentrum Ruhrgebiet Herne
Herne, Germany
- Klinikum Der Universität München Rheumatologie
München, Germany
- Rheumazentrum Ratingen
Ratingen, Germany
- Qualiclinic Kft.
Budapest, Hungary
- Cru Hungary Ltd
Miskolc, Hungary
- Máv Kórház És Rendelőintézet, Reumtólegia
Szolnok, Hungary
- Vital Medical Center
Veszprém, Hungary
- Nasz Lekarz Ośrodek Badań Klinicznych
Bydgoszcz, Poland
- Pratia Mcm Krakow
Krakow, Poland
- Centrum Medyczne Amed Oddział W Łodzi
Lodz, Poland
- Etyka Ośrodek Badań Klinicznych
Olsztyn, Poland
- Etg Skierniewice
Skierniewice, Poland
- Centrum Medyczne Amed
Warsaw, Poland
- Etg Warszawa
Warsaw, Poland
- Complejo Hospitalario Universitario de A Coruña
A Coruña, Spain
- Hospital Universitario Reina Sofía 1 Planta Derecha Servicio Reumatología- Imibic
Córdoba, Spain
- Cliníca Ceta - Unidad de Ensayos Clínicos
Madrid, Spain
- Hospital Parc Tauli de Sabadell
Sabadell, Spain
- Complejo Hospitalario Universitario de Santiago de Compostela Hospital Clinico Universitario
Santiago de Compostela, Spain
- Hospital Quironsalud Infanta Luisa Unidad de Investigación de Reumatología
Seville, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Aug 2020
- Primary completion
- 1 Oct 2021
- Completion
- 27 Jan 2022
- Last update posted
- 9 Feb 2024
- Registered enrollment
- 129
- Registry id
- NCT04713072
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.